Meanwhile, it promotes the secretion of extracellular active pro-inflammatory cytokines IL-1β and IL-18 (Hooftman et al., 2020), which intensifies the liver inflammatory response and accelerates the development of MASLD. Here, IL18 is linked to metabolic dysfunction-associated steatotic liver disease.